PharmAcumen Consulting Inc. is categorized under Biotechnology Products and Services in Franklin, MA and active since 2009.
PharmAcumen Consulting Inc. was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Biotechnology Products and Services business, which does work in the B2B market, and is classified as a Biotechnology Products and Services, under code number by the NAICS.
If you are seeking more information, feel free to contact Diane McGuire at the company’s headquarters by writing to 4 Tia Place, Franklin, Massachusetts MA 02038 or by phoning (617) 858-1289. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | PharmAcumen Consulting Inc. |
| Contact Person: | Diane McGuire |
| Address: | 4 Tia Place, Franklin, Massachusetts 02038 |
| Phone Number: | (617) 858-1289 |
| Website Address: | pharmacumen.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biotechnology Products and Services |
| Share This Business: |
PharmAcumen Consulting Inc. was started in 2009 to provide professional Biotechnology Products and Services under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Diane McGuire for inquiries that concern PharmAcumen Consulting Inc. by calling the company number (617) 858-1289, as your correspondence is most welcome. Additionally, the physical location of the headquarters of PharmAcumen Consulting Inc. can be found at the coordinates 42.04569,-71.44979 as well as the street address 4 Tia Place in Franklin, Massachusetts 02038.
For its online presence, you may visit PharmAcumen Consulting Inc.’s website at pharmacumen.com and engage with its social media outlets through on Twitter and on Facebook.